APA Alıntı

Williams, K. J., Telfer, B. A., Stratford, I. J., & Wedge, S. R. (2002). ZD1839 (‘Iressa’), a specific oral epidermal growth factor receptor-tyrosine kinase inhibitor, potentiates radiotherapy in a human colorectal cancer xenograft model. Nature Publishing Group.

Chicago Stili Alıntı

Williams, K J., B A. Telfer, I J. Stratford, ve S R. Wedge. ZD1839 (‘Iressa’), a Specific Oral Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor, Potentiates Radiotherapy in a Human Colorectal Cancer Xenograft Model. Nature Publishing Group, 2002.

MLA Alıntı

Williams, K J., B A. Telfer, I J. Stratford, ve S R. Wedge. ZD1839 (‘Iressa’), a Specific Oral Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor, Potentiates Radiotherapy in a Human Colorectal Cancer Xenograft Model. Nature Publishing Group, 2002.